Eliana Merle
Stock Analyst at UBS
(0.07)
# 4,136
Out of 4,829 analysts
80
Total ratings
12.5%
Success rate
-34.72%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Eliana Merle
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MRNA Moderna | Maintains: Buy | $78 → $70 | $25.70 | +172.37% | 7 | May 2, 2025 | |
| MDGL Madrigal Pharmaceuticals | Maintains: Buy | $441 → $458 | $300.76 | +52.28% | 4 | May 2, 2025 | |
| CVAC CureVac | Maintains: Buy | $13 → $12 | $3.62 | +231.49% | 2 | Apr 30, 2025 | |
| BBIO BridgeBio Pharma | Maintains: Buy | $65 → $72 | $35.68 | +101.79% | 3 | Apr 30, 2025 | |
| APLS Apellis Pharmaceuticals | Initiates: Overweight | $44 | $17.52 | +151.14% | 8 | Apr 29, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Buy | $109 → $113 | $61.37 | +84.13% | 2 | Feb 20, 2025 | |
| ETNB 89bio | Maintains: Buy | $25 → $38 | $8.11 | +368.56% | 3 | Jan 31, 2025 | |
| AKRO Akero Therapeutics | Maintains: Buy | $42 → $109 | $41.53 | +162.46% | 4 | Jan 31, 2025 | |
| ZNTL Zentalis Pharmaceuticals | Maintains: Neutral | $5 → $2.2 | $1.29 | +70.54% | 4 | Jan 28, 2025 | |
| RVMD Revolution Medicines | Maintains: Buy | $65 → $71 | $41.88 | +69.53% | 2 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $196 | $154.43 | +26.92% | 1 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $10.26 | +172.90% | 1 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $3.31 | +262.54% | 1 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $3 | $3.55 | -15.49% | 1 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $26 | $6.01 | +332.61% | 1 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $74 | $32.17 | +130.03% | 2 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $23 → $33 | $20.03 | +64.75% | 4 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $97 → $131 | $97.27 | +34.68% | 6 | Sep 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $2 | $0.88 | +127.58% | 2 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $253 → $288 | $270.19 | +6.59% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3 → $5 | $4.14 | +20.92% | 3 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $18 | $3.02 | +496.03% | 2 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $42 | $13.15 | +219.39% | 4 | May 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $8 | $1.10 | +627.27% | 2 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $4.27 | +415.22% | 1 | Oct 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $51 → $47 | $7.97 | +489.71% | 1 | Jun 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $6.22 | +157.44% | 2 | May 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $123 | $6.52 | +1,786.50% | 3 | May 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $192 → $134 | $25.07 | +434.50% | 3 | Aug 19, 2020 |
Moderna
May 2, 2025
Maintains: Buy
Price Target: $78 → $70
Current: $25.70
Upside: +172.37%
Madrigal Pharmaceuticals
May 2, 2025
Maintains: Buy
Price Target: $441 → $458
Current: $300.76
Upside: +52.28%
CureVac
Apr 30, 2025
Maintains: Buy
Price Target: $13 → $12
Current: $3.62
Upside: +231.49%
BridgeBio Pharma
Apr 30, 2025
Maintains: Buy
Price Target: $65 → $72
Current: $35.68
Upside: +101.79%
Apellis Pharmaceuticals
Apr 29, 2025
Initiates: Overweight
Price Target: $44
Current: $17.52
Upside: +151.14%
BioMarin Pharmaceutical
Feb 20, 2025
Maintains: Buy
Price Target: $109 → $113
Current: $61.37
Upside: +84.13%
89bio
Jan 31, 2025
Maintains: Buy
Price Target: $25 → $38
Current: $8.11
Upside: +368.56%
Akero Therapeutics
Jan 31, 2025
Maintains: Buy
Price Target: $42 → $109
Current: $41.53
Upside: +162.46%
Zentalis Pharmaceuticals
Jan 28, 2025
Maintains: Neutral
Price Target: $5 → $2.2
Current: $1.29
Upside: +70.54%
Revolution Medicines
Jan 8, 2025
Maintains: Buy
Price Target: $65 → $71
Current: $41.88
Upside: +69.53%
Jan 7, 2025
Initiates: Buy
Price Target: $196
Current: $154.43
Upside: +26.92%
Jan 7, 2025
Initiates: Buy
Price Target: $28
Current: $10.26
Upside: +172.90%
Nov 12, 2024
Initiates: Buy
Price Target: $12
Current: $3.31
Upside: +262.54%
Nov 12, 2024
Initiates: Neutral
Price Target: $3
Current: $3.55
Upside: -15.49%
Nov 12, 2024
Initiates: Buy
Price Target: $26
Current: $6.01
Upside: +332.61%
Nov 4, 2024
Maintains: Buy
Price Target: $80 → $74
Current: $32.17
Upside: +130.03%
Oct 30, 2024
Maintains: Neutral
Price Target: $23 → $33
Current: $20.03
Upside: +64.75%
Sep 18, 2024
Maintains: Neutral
Price Target: $97 → $131
Current: $97.27
Upside: +34.68%
Sep 9, 2024
Maintains: Neutral
Price Target: $10 → $2
Current: $0.88
Upside: +127.58%
Jun 28, 2024
Maintains: Buy
Price Target: $253 → $288
Current: $270.19
Upside: +6.59%
Apr 4, 2024
Maintains: Neutral
Price Target: $3 → $5
Current: $4.14
Upside: +20.92%
Mar 27, 2024
Maintains: Buy
Price Target: $19 → $18
Current: $3.02
Upside: +496.03%
May 19, 2023
Maintains: Buy
Price Target: $45 → $42
Current: $13.15
Upside: +219.39%
Dec 7, 2022
Maintains: Buy
Price Target: $19 → $8
Current: $1.10
Upside: +627.27%
Oct 13, 2022
Initiates: Buy
Price Target: $22
Current: $4.27
Upside: +415.22%
Jun 23, 2022
Maintains: Buy
Price Target: $51 → $47
Current: $7.97
Upside: +489.71%
May 21, 2021
Initiates: Buy
Price Target: $16
Current: $6.22
Upside: +157.44%
May 21, 2021
Initiates: Buy
Price Target: $123
Current: $6.52
Upside: +1,786.50%
Aug 19, 2020
Maintains: Neutral
Price Target: $192 → $134
Current: $25.07
Upside: +434.50%